Related Experiment Videos
Pathobiology of hepatitis C
1Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Insights
Hepatitis C virus (HCV) causes non-A, non-B hepatitis, leading to liver damage. Detecting HCV RNA in liver tissue via in situ hybridization is more sensitive than antibody staining for understanding viral load and disease progression.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) is a primary cause of non-A, non-B hepatitis.
- Hepatitis C pathology involves lymphoid aggregates, bile duct damage, and steatosis in the liver.
- HCV infection triggers host immune responses and potentially direct viral damage to hepatocytes and bile ducts.
Purpose of the Study:
- To investigate methods for detecting Hepatitis C virus (HCV) in infected liver tissues.
- To compare the sensitivity of immunohistochemical staining versus in situ hybridization for HCV detection.
- To understand the viral load and expression patterns of HCV in the liver.
Main Methods:
- Immunohistochemical staining using antibodies to detect HCV antigens in hepatocytes.
- In situ hybridization to detect HCV RNA sequences in fixed liver tissues.
- Analysis of pathological changes including lymphoid aggregates, bile duct damage, and steatosis.
Main Results:
- HCV antigens are detectable in infected hepatocytes, especially in frozen tissues.
- In situ hybridization for HCV RNA in fixed liver tissues shows higher sensitivity than immunohistochemical staining.
- These methods are crucial for determining viral load and HCV expression in the liver.
Conclusions:
- In situ hybridization is a more sensitive method for detecting HCV in liver tissue compared to immunohistochemistry.
- Understanding viral load and expression patterns is key to studying HCV pathogenesis.
- Both immune response and direct viral effects likely contribute to liver injury in Hepatitis C.
Abstract:
Hepatitis C virus (HCV) represents the major etiologic agent of non-A, non-B hepatitis. The pathological changes in hepatitis C are characterized by the histologic triad of lymphoid aggregates in portal tracts, epithelial damage of small bile ducts, and micro- and macro-vesicular steatosis. HCV antigens are demonstrable in the cytoplasm of infected hepatocytes by immunohistochemical staining with mono- or polyclonal antibodies, particularly when frozen tissues are employed. Detection of HCV RNA sequences in fixed liver tissues by in situ hybridization appears to be a more sensitive method than immunohistochemical staining. These studies are important to determine the viral load and expression pattern of HCV in the infected liver. The mechanism of hepatocyte and bile duct injury in HCV infection appears to be related to the host immune response to the virus, although direct viral cytopathogenicity may also pay a role.